DNTH vs DVA · rev $6.2M vs P/E 14, rev $12.82B
Dianthus Therapeutics Inc. (DNTH) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
DNTH currently screens at market cap $4.40B. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the DNTH and DVA stock pages for the full models.
Not investment advice.